TapewireFind a company

person · Reporting owner

Pylypiv Mariya

Disclosed activity across 2 companies

Tapewire entity
10116
SEC CIK
0001865982

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
AIRO Group Holdings, Inc.AIRO · Entity 6200Chief Financial OfficerSeptember 02, 2026September 04, 2026
UpHealth, Inc.UPHL · Entity 88003DirectorJanuary 31, 2024February 02, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AIRO Group Holdings, Inc.

Report date September 02, 2026 · Filed September 04, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect267,333 Reported balance After 2026-09-02 transaction · row 1
1 source row

Row 1 · 2026-09-02 · Sale · Disposed 8,697 · Balance 267,333

F1: The shares were sold to cover tax withholding obligations associated with the settlement of restricted stock units.

F2: The weighted average sales price for the transaction reported was $7.0821, and the range of prices was between $6.89 and $7.30, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Common StockSEC Table I · non-derivativeIndirectBy Persistent LLC250 Reported balance Holding disclosure · report date 2026-09-02 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 250

F3: The Reporting Person is the sole member of Persistent LLC.

Filing footnotes · ownership attribution and instrument terms

F1: The shares were sold to cover tax withholding obligations associated with the settlement of restricted stock units.

F2: The weighted average sales price for the transaction reported was $7.0821, and the range of prices was between $6.89 and $7.30, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

F3: The Reporting Person is the sole member of Persistent LLC.

UpHealth, Inc.

Report date January 31, 2024 · Filed February 02, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect795,714 Reported balance After 2024-01-31 transaction · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · 2024-01-31 · Grant · Acquired 100,000 · Balance 795,714

F2: Subject to the Reporting Person's continued service to the Company, the Restricted Stock Units ("RSUs") shall vest on January 1, 2025; all RSUs shall immediately vest in the event of a Change of Control (as defined in the UpHealth, Inc. 2021 Equity Incentive Plan) of the Company.

Common StockSEC Table I · non-derivativeDirect695,714 Reported balance Holding disclosure · report date 2024-01-31 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 695,714

F1: Includes Restricted Stock Units ("Prior RSUs") of UpHealth, Inc. (the "Company"), that are subject to vesting pursuant to previously disclosed vesting schedules.

Filing footnotes · ownership attribution and instrument terms

F1: Includes Restricted Stock Units ("Prior RSUs") of UpHealth, Inc. (the "Company"), that are subject to vesting pursuant to previously disclosed vesting schedules.

F2: Subject to the Reporting Person's continued service to the Company, the Restricted Stock Units ("RSUs") shall vest on January 1, 2025; all RSUs shall immediately vest in the event of a Change of Control (as defined in the UpHealth, Inc. 2021 Equity Incentive Plan) of the Company.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 02, 2026 Filed Sep 4, 2026 20:30 UTC AIRO Group Holdings, Inc. AIRO · Entity 6200 SaleCommon Stock 8,697 $7.08 $61,593.02
Disclosure

SEC source: 0001865982-26-000011 · form4-09042026_040903.xml · nonDerivative · entry 1

Pylypiv Mariya · CIK 0001865982 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,333

F1 · kind: The shares were sold to cover tax withholding obligations associated with the settlement of restricted stock units.

F2 · price: The weighted average sales price for the transaction reported was $7.0821, and the range of prices was between $6.89 and $7.30, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 20:15 UTC AIRO Group Holdings, Inc. AIRO · Entity 6200 SaleCommon Stock 1,699 $10.86 $18,451.65
Disclosure

SEC source: 0001865982-26-000009 · form4-08182026_080854.xml · nonDerivative · entry 3

Pylypiv Mariya · CIK 0001865982 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 276,030

F2 · kind: The shares were sold to cover tax withholding obligations associated with the settlement of restricted stock units.

F4 · price: The weighted average sales price for the transaction reported was $10.8603, and the range of prices was between $10.44 and $11.27, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
August 14, 2026 Filed Aug 18, 2026 20:15 UTC AIRO Group Holdings, Inc. AIRO · Entity 6200 SaleCommon Stock 17,690 $9.61 $170,080.51
Disclosure

SEC source: 0001865982-26-000009 · form4-08182026_080854.xml · nonDerivative · entry 2

Pylypiv Mariya · CIK 0001865982 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 277,729

F2 · kind: The shares were sold to cover tax withholding obligations associated with the settlement of restricted stock units.

F3 · price: The weighted average sales price for the transaction reported was $9.6145, and the range of prices was between $9.41 and $10.22, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
August 13, 2026 Filed Aug 18, 2026 20:15 UTC AIRO Group Holdings, Inc. AIRO · Entity 6200 GrantCommon Stock 215,231 $0.00 $0.00
Disclosure

SEC source: 0001865982-26-000009 · form4-08182026_080854.xml · nonDerivative · entry 1

Pylypiv Mariya · CIK 0001865982 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 295,419

F1 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. On August 13, 2026, 1/6 of the RSU vested, with the remainder vesting in ten quarterly installments beginning on September 1, 2026, subject to the Reporting Person's continued employment with the Issuer through each such vesting date.

Read SEC document
June 17, 2026 Filed Jun 18, 2026 20:15 UTC AIRO Group Holdings, Inc. AIRO · Entity 6200 SaleCommon Stock 30,028 $7.66 $229,921.39
Disclosure

SEC source: 0001865982-26-000006 · form4-06182026_040616.xml · nonDerivative · entry 2

Pylypiv Mariya · CIK 0001865982 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,188

F2 · kind: The shares were sold to cover tax withholding obligations associated with the settlement of the RSUs.

F3 · price: The weighted average sales price for the transaction reported was $7.6569, and the range of prices was between $7.385 and $7.84, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 20:15 UTC AIRO Group Holdings, Inc. AIRO · Entity 6200 GrantCommon Stock 60,329 $0.00 $0.00
Disclosure

SEC source: 0001865982-26-000006 · form4-06182026_040616.xml · nonDerivative · entry 1

Pylypiv Mariya · CIK 0001865982 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,216

F1 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vested in full upon the date of grant.

Read SEC document
March 12, 2026 Filed Mar 17, 2026 01:26 UTC AIRO Group Holdings, Inc. AIRO · Entity 6200 SaleCommon Stock 20,078 $10.26 $205,974.18
Disclosure

SEC source: 0001865982-26-000002 · form4-03172026_010322.xml · nonDerivative · entry 1

Pylypiv Mariya · CIK 0001865982 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,887

F1 · kind: The shares were sold to cover tax withholding obligations associated with the settlement of restricted stock units.

F2 · price: The weighted average sales price for the transaction reported was $10.2587, and the range of prices was between $9.99 and $10.4716, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

F3 · balance_after: The total reflects a withholding for tax liability of 10,035 shares in connection with a bonus award reported by the Reporting Person on a Form 4 filed on June 18, 2025 (the "June 2025 Form 4") that was not previously reported. The total also reflects the reduction of 2,500 shares that were incorrectly reported as directly held by the Reporting Person on the June 2025 Form 4, which shares should have been reported as indirectly held, as now correctly reflected on this Form 4.

Read SEC document
June 16, 2025 Filed Jun 19, 2025 01:31 UTC AIRO Group Holdings, Inc. AIRO · Entity 6200 ConversionInvestor Notes · Derivative 2,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017750 · form4-06192025_010603.xml · derivative · entry 4

Pylypiv Mariya · CIK 0001865982 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares issued to the Reporting Person upon the closing of the Issuer's initial public offering pursuant to a one-time interest payment of $10.8 million by the Issuer for interest payable in connection with notes issued to certain investors including the Reporting Person.

F1 · derivative.exercise_date: Represents shares issued to the Reporting Person upon the closing of the Issuer's initial public offering pursuant to a one-time interest payment of $10.8 million by the Issuer for interest payable in connection with notes issued to certain investors including the Reporting Person.

F1 · derivative.expiration_date: Represents shares issued to the Reporting Person upon the closing of the Issuer's initial public offering pursuant to a one-time interest payment of $10.8 million by the Issuer for interest payable in connection with notes issued to certain investors including the Reporting Person.

Read SEC document
June 16, 2025 Filed Jun 19, 2025 01:31 UTC AIRO Group Holdings, Inc. AIRO · Entity 6200 GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-017750 · form4-06192025_010603.xml · nonDerivative · entry 3

Pylypiv Mariya · CIK 0001865982 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,500

F3 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vested in full upon the date of grant.

Read SEC document
June 16, 2025 Filed Jun 19, 2025 01:31 UTC AIRO Group Holdings, Inc. AIRO · Entity 6200 GrantCommon Stock 30,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-017750 · form4-06192025_010603.xml · nonDerivative · entry 2

Pylypiv Mariya · CIK 0001865982 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,500

F2 · kind: Represents shares awarded as a bonus to the Reporting Person with a value of $300,000.

F2 · price: Represents shares awarded as a bonus to the Reporting Person with a value of $300,000.

Read SEC document
June 16, 2025 Filed Jun 19, 2025 01:31 UTC AIRO Group Holdings, Inc. AIRO · Entity 6200 ConversionCommon Stock 2,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-25-017750 · form4-06192025_010603.xml · nonDerivative · entry 1

Pylypiv Mariya · CIK 0001865982 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares issued to the Reporting Person upon the closing of the Issuer's initial public offering pursuant to a one-time interest payment of $10.8 million by the Issuer for interest payable in connection with notes issued to certain investors including the Reporting Person.

F1 · price: Represents shares issued to the Reporting Person upon the closing of the Issuer's initial public offering pursuant to a one-time interest payment of $10.8 million by the Issuer for interest payable in connection with notes issued to certain investors including the Reporting Person.

Read SEC document
June 16, 2025 Filed May 26, 2026 21:00 UTC Amendment AIRO Group Holdings, Inc. AIRO · Entity 6200 ConversionInvestor Notes · Derivative 250 $0.00 $0.00
Disclosure

SEC source: 0001865982-26-000004 · form4a-05262026_050503.xml · derivative · entry 3

Pylypiv Mariya · CIK 0001865982 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Persistent LLC

Disclosed balance after: 0

Underlying: Common Stock · 250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Represents shares issued to Persistent LLC upon the closing of the Issuer's initial public offering as a one-time contingent interest payment of $2,500 paid in shares of common stock pursuant to a note issued to Persistent LLC.

F2 · shares: On June 18, 2025, the Reporting Person filed a Form 4 which inadvertently reported that 2,500 shares were issued to the Reporting Person upon the closing of the Issuer's initial public offering as a one-time contingent interest payment of $2,500 paid in shares of common stock pursuant to a note issued to the Reporting Person. In fact, as reported in this amendment, only 250 shares were issued and such shares were issued to Persistent LLC, not to the Reporting Person.

F1 · derivative.exercise_date: Represents shares issued to Persistent LLC upon the closing of the Issuer's initial public offering as a one-time contingent interest payment of $2,500 paid in shares of common stock pursuant to a note issued to Persistent LLC.

F1 · derivative.expiration_date: Represents shares issued to Persistent LLC upon the closing of the Issuer's initial public offering as a one-time contingent interest payment of $2,500 paid in shares of common stock pursuant to a note issued to Persistent LLC.

F3 · ownership.nature: The Reporting Person is the sole member of Persistent LLC.

Read SEC document
June 16, 2025 Filed May 26, 2026 21:00 UTC Amendment AIRO Group Holdings, Inc. AIRO · Entity 6200 GrantCommon Stock 19,965 Not disclosed Not disclosed
Disclosure

SEC source: 0001865982-26-000004 · form4a-05262026_050503.xml · nonDerivative · entry 2

Pylypiv Mariya · CIK 0001865982 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,965

F4 · kind: Represents net shares issued to the Reporting Person in connection with a bonus award with a value of $300,000 pursuant to the terms of an employment agreement by and between the Issuer and the Reporting Person.

F5 · shares: On June 18, 2025, the Reporting Person filed a Form 4 which inadvertently reported that 30,000 shares were issued as a bonus with a value of $300,000. In fact, as reported in this amendment, only 19,965 shares were issued due to the withholding of 10,035 shares to satisfy tax withholding obligations.

F4 · price: Represents net shares issued to the Reporting Person in connection with a bonus award with a value of $300,000 pursuant to the terms of an employment agreement by and between the Issuer and the Reporting Person.

Read SEC document
June 16, 2025 Filed May 26, 2026 21:00 UTC Amendment AIRO Group Holdings, Inc. AIRO · Entity 6200 ConversionCommon Stock 250 Not disclosed Not disclosed
Disclosure

SEC source: 0001865982-26-000004 · form4a-05262026_050503.xml · nonDerivative · entry 1

Pylypiv Mariya · CIK 0001865982 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Persistent LLC

Disclosed balance after: 250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares issued to Persistent LLC upon the closing of the Issuer's initial public offering as a one-time contingent interest payment of $2,500 paid in shares of common stock pursuant to a note issued to Persistent LLC.

F2 · shares: On June 18, 2025, the Reporting Person filed a Form 4 which inadvertently reported that 2,500 shares were issued to the Reporting Person upon the closing of the Issuer's initial public offering as a one-time contingent interest payment of $2,500 paid in shares of common stock pursuant to a note issued to the Reporting Person. In fact, as reported in this amendment, only 250 shares were issued and such shares were issued to Persistent LLC, not to the Reporting Person.

F1 · price: Represents shares issued to Persistent LLC upon the closing of the Issuer's initial public offering as a one-time contingent interest payment of $2,500 paid in shares of common stock pursuant to a note issued to Persistent LLC.

F3 · ownership.nature: The Reporting Person is the sole member of Persistent LLC.

Read SEC document
January 31, 2024 Filed Feb 2, 2024 23:21 UTC UpHealth, Inc. UPHL · Entity 88003 GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001062993-24-001877 · form4.xml · nonDerivative · entry 2

Pylypiv Mariya · CIK 0001865982 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 795,714

F2 · shares: Subject to the Reporting Person's continued service to the Company, the Restricted Stock Units ("RSUs") shall vest on January 1, 2025; all RSUs shall immediately vest in the event of a Change of Control (as defined in the UpHealth, Inc. 2021 Equity Incentive Plan) of the Company.

Read SEC document
September 09, 2022 Filed Oct 14, 2022 21:38 UTC UpHealth, Inc. UPH · Entity 88003 OtherCommon Stock, $0.0001 par value 811,635 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-033678 · doc4.xml · nonDerivative · entry 1

Pylypiv Mariya · CIK 0001865982 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,741,033

F1 · kind: Transfer of shares of UpHealth, Inc. common stock (such shares, the "Subject Shares") by the Reporting Person, under a reservation of rights, to certain members of Cloudbreak Health, LLC ("Cloudbreak") pursuant to an escrow agreement dated June 15, 2021 that was entered into in connection with a Business Combination Agreement dated November 20, 2020, as amended (the "BCA"), between UpHealth, Inc. (f/k/a GigCapital2, Inc.), UpHealth Holdings, Inc. ("Holdings"), Cloudbreak, Cloudbreak Health Merger Sub, LLC, Chirinjeev Kathuria, and the Reporting Person. The Reporting Person originally received the Subject Shares in exchange for shares of Holdings in connection with the merger of Holdings into an UpHealth, Inc. subsidiary pursuant to the exchange ratio set forth in the BCA. The closing price of the Subject Shares on the effective date of the merger was $9.38.

F1 · price: Transfer of shares of UpHealth, Inc. common stock (such shares, the "Subject Shares") by the Reporting Person, under a reservation of rights, to certain members of Cloudbreak Health, LLC ("Cloudbreak") pursuant to an escrow agreement dated June 15, 2021 that was entered into in connection with a Business Combination Agreement dated November 20, 2020, as amended (the "BCA"), between UpHealth, Inc. (f/k/a GigCapital2, Inc.), UpHealth Holdings, Inc. ("Holdings"), Cloudbreak, Cloudbreak Health Merger Sub, LLC, Chirinjeev Kathuria, and the Reporting Person. The Reporting Person originally received the Subject Shares in exchange for shares of Holdings in connection with the merger of Holdings into an UpHealth, Inc. subsidiary pursuant to the exchange ratio set forth in the BCA. The closing price of the Subject Shares on the effective date of the merger was $9.38.

Read SEC document
August 01, 2022 Filed Aug 24, 2022 01:56 UTC UpHealth, Inc. UPH · Entity 88003 Tax withholdingCommon Stock, $0.0001 par value 3,742 $0.65 $2,433.42
Disclosure

SEC source: 0000899243-22-029571 · doc4.xml · nonDerivative · entry 1

Pylypiv Mariya · CIK 0001865982 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,552,668

Read SEC document
November 18, 2021 Filed Nov 19, 2021 22:47 UTC UpHealth, Inc. UPH · Entity 88003 PurchaseCommon Stock 16,737 $3.40 $56,905.80
Disclosure

SEC source: 0001062993-21-011264 · form4.xml · nonDerivative · entry 6

Pylypiv Mariya · CIK 0001865982 · Director · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,647,084

Read SEC document
November 18, 2021 Filed Nov 19, 2021 22:47 UTC UpHealth, Inc. UPH · Entity 88003 PurchaseCommon Stock 645 $3.35 $2,160.75
Disclosure

SEC source: 0001062993-21-011264 · form4.xml · nonDerivative · entry 5

Pylypiv Mariya · CIK 0001865982 · Director · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,630,347

Read SEC document
November 17, 2021 Filed Nov 19, 2021 22:47 UTC UpHealth, Inc. UPH · Entity 88003 PurchaseCommon Stock 10,000 $3.42 $34,200.00
Disclosure

SEC source: 0001062993-21-011264 · form4.xml · nonDerivative · entry 4

Pylypiv Mariya · CIK 0001865982 · Director · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,629,702

Read SEC document
November 17, 2021 Filed Nov 19, 2021 22:47 UTC UpHealth, Inc. UPH · Entity 88003 PurchaseCommon Stock 2,618 $3.40 $8,901.20
Disclosure

SEC source: 0001062993-21-011264 · form4.xml · nonDerivative · entry 3

Pylypiv Mariya · CIK 0001865982 · Director · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,619,702

Read SEC document
October 20, 2021 Filed Nov 19, 2021 22:47 UTC UpHealth, Inc. UPH · Entity 88003 GrantPerformance-Based Restricted Stock Unit · Derivative 155,440 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001062993-21-011264 · form4.xml · derivative · entry 7

Pylypiv Mariya · CIK 0001865982 · Director · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,440

Underlying: Common Stock · 155,440 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance-based RSU represents the right to receive, following vesting, one share of the Company's common stock ("Common Stock"). The number of shares of Common Stock acquired upon vesting of the performance-based RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Board of Directors on an annual basis over three one-year performance periods beginning on the first day of the fiscal year of 2021 and ending on the last day of the fiscal year of 2023.

F2 · derivative.exercise_date: Each performance-based RSU represents the right to receive, following vesting, one share of the Company's common stock ("Common Stock"). The number of shares of Common Stock acquired upon vesting of the performance-based RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Board of Directors on an annual basis over three one-year performance periods beginning on the first day of the fiscal year of 2021 and ending on the last day of the fiscal year of 2023.

F2 · derivative.expiration_date: Each performance-based RSU represents the right to receive, following vesting, one share of the Company's common stock ("Common Stock"). The number of shares of Common Stock acquired upon vesting of the performance-based RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Board of Directors on an annual basis over three one-year performance periods beginning on the first day of the fiscal year of 2021 and ending on the last day of the fiscal year of 2023.

Read SEC document
October 20, 2021 Filed Nov 19, 2021 22:47 UTC UpHealth, Inc. UPH · Entity 88003 GrantCommon Stock 155,440 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-011264 · form4.xml · nonDerivative · entry 2

Pylypiv Mariya · CIK 0001865982 · Director · Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,617,084

F1 · shares: Subject to the Reporting Person's continued service to UpHealth, Inc. (the "Company"), 1/3 of the Restricted Stock Unit ("RSUs") shall vest on May 1, 2022 (the "Initial Vesting Date"), and the remaining 2/3 of the RSUs shall vest quarterly on each of three month anniversary following the Initial Vesting Date until fully vested.

Read SEC document
June 09, 2021 Filed Jun 11, 2021 22:11 UTC UpHealth, Inc. UPH · Entity 88003 GrantCommon Stock 7,461,644 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-21-020699 · form4.xml · nonDerivative · entry 1

Pylypiv Mariya · CIK 0001865982 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,461,644

F1 · price: Received in exchange for 691,000 shares of UpHealth Holdings, Inc. ("Holdings") in connection with the merger of Holdings into a subsidiary of UpHealth, Inc. (the "Company") pursuant to the exchange ratio set forth in the business combination agreement between Holdings and the Company. The closing price of the Company's Common Stock on the effective date of the merger was $9.38.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.